Clinical trials
Phase 3 Cardiovascular Diseases trials in New Zealand
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Terminated | 4 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| GlaxoSmithKline | 3 |
| Pfizer | 2 |
| Alnylam Pharmaceuticals | 1 |
| Amarin Pharma Inc. | 1 |
| AstraZeneca | 1 |
| Boehringer Ingelheim | 1 |
| CSL Behring | 1 |
| Esperion Therapeutics, Inc. | 1 |
| Hamilton Health Sciences Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 20 |
| Heart Diseases | 6 |
| Atherosclerosis | 5 |
| Diabetes Mellitus, Type 2 | 5 |
| Acute Coronary Syndrome | 4 |
| Myocardial Infarction | 4 |
| Coronary Artery Disease | 3 |
| Coronary Disease | 3 |
| Hypertension | 3 |
| Stroke | 3 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.